Literature DB >> 2294239

Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis.

J B Thrasher1, G J Miller, J N Wettlaufer.   

Abstract

We report 2 cases of leiomyosarcoma of the bladder that occurred after long-term cyclophosphamide chemotherapy for lupus nephritis and rheumatoid arthritis. One patient had a tumor at the end of an 11-year course of chemotherapy and 1 approximately 7 years after completing a 7-year course of chemotherapy. Patient 1 underwent left partial cystectomy and patient 2 underwent cystectomy with ileal conduit urinary diversion. In patient 1 the tumor was a typical leiomyosarcoma and patient 2 had a myxoid variant. Both patients were free of disease at 4 months and 3 years, respectively. Whereas previous reports of the carcinogenic effects of cyclophosphamide have been questioned, since the induced tumors occurred in patients being treated for other neoplasms (lymphoproliferative and myeloproliferative disorders), the disease in both of our patients followed cyclophosphamide therapy for nonneoplastic disorders.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2294239     DOI: 10.1016/s0022-5347(17)39886-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

Review 1.  Cyclophosphamide toxicity. Characterising and avoiding the problem.

Authors:  L H Fraiser; S Kanekal; J P Kehrer
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 2.  Combination therapy: the risks of infection and tumor induction.

Authors:  D E Yocum
Journal:  Springer Semin Immunopathol       Date:  2001

Review 3.  Malignancy and systemic lupus erythematosus.

Authors:  Sasha Bernatsky; Ann Clarke; Rosalind Ramsey-Goldman
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

4.  Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.

Authors:  Arti Parikh-Patel; Richard H White; Mark Allen; Rosemary Cress
Journal:  Cancer Causes Control       Date:  2008-04-02       Impact factor: 2.506

Review 5.  Leiomyosarcoma of the urinary bladder presenting as life threatening gross hematuria.

Authors:  Thomas Nelius; J Stevens; C Samathanam; S Filleur
Journal:  Med Oncol       Date:  2009-06-11       Impact factor: 3.064

6.  Urinary bladder leiomyosarcoma in adults.

Authors:  Apostolos P Labanaris; Vahudin Zugor; Bernd Meyer; Reinhold Nützel; Stephan Helmus; Panagiotis G Labanaris; Reinhard Kühn
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

7.  Bladder leiomyosarcoma: report of three cases.

Authors:  O Ozteke; A Demirel; N E Aydin; L Memiş
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

8.  Incidence of cancer among female patients with systemic lupus erythematosus in Korea.

Authors:  Kwi Young Kang; Hyun Ok Kim; Ho Sung Yoon; Jeniffer Lee; Won Chul Lee; Hyek-Jae Ko; Ji Hyeon Ju; Chul-Soo Cho; Ho-Youn Kim; Sung-Hwan Park
Journal:  Clin Rheumatol       Date:  2009-12-30       Impact factor: 3.650

9.  Simultaneous Low- and High-Grade Primary Leiomyosarcomas in Two Separate Organs in a Thirty-Year Survivor of Hereditary Retinoblastoma.

Authors:  Katherine Moore; Ossama Tawfik; Allyson Hays; Isaac Opole
Journal:  Case Rep Oncol Med       Date:  2015-12-30

10.  Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.

Authors:  Claire T Deakin; Raquel Campanilho-Marques; Stefania Simou; Elena Moraitis; Lucy R Wedderburn; Eleanor Pullenayegum; Clarissa A Pilkington
Journal:  Arthritis Rheumatol       Date:  2018-03-25       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.